Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

[Relation between cardio-ankle vascular index (Cavi) and preheparin serum lipoprotein lipase mass--effect of age adjustment].

Moteki M, Murano T, Kurosu T, Kataoka M, Nakano M, Hiruta N, Shirai K.

Rinsho Byori. 2012 Aug;60(8):734-9. Japanese.

PMID:
23198531
2.
3.

Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects.

Wang H, Liu J, Zhao H, Fu X, Shang G, Zhou Y, Yu X, Zhao X, Wang G, Shi H.

J Am Soc Hypertens. 2013 Nov-Dec;7(6):426-31. doi: 10.1016/j.jash.2013.06.003. Epub 2013 Jul 18.

PMID:
23871571
4.

Association between urinary 8-hydroxydeoxyguanosine, an indicator of oxidative stress, and the cardio-ankle vascular index in hypertensive patients.

Masugata H, Senda S, Murao K, Inukai M, Himoto T, Hosomi N, Okada H, Goda F.

J Atheroscler Thromb. 2012;19(8):747-55. Epub 2012 Apr 28.

5.

Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives.

Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M.

J Atheroscler Thromb. 2011;18(11):924-38. Epub 2011 May 31. Review.

6.

Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure.

Ibata J, Sasaki H, Kakimoto T, Matsuno S, Nakatani M, Kobayashi M, Tatsumi K, Nakano Y, Wakasaki H, Furuta H, Nishi M, Nanjo K.

Diabetes Res Clin Pract. 2008 May;80(2):265-70. doi: 10.1016/j.diabres.2007.12.016. Epub 2008 Feb 1.

PMID:
18242761
7.

Effects of body weight reduction on cardio-ankle vascular index (CAVI).

Nagayama D, Endo K, Ohira M, Yamaguchi T, Ban N, Kawana H, Nagumo A, Saiki A, Oyama T, Miyashita Y, Shirai K.

Obes Res Clin Pract. 2013 Mar-Apr;7(2):e139-e145. doi: 10.1016/j.orcp.2011.08.154.

PMID:
24331775
8.

Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI).

Shirai K, Utino J, Saiki A, Endo K, Ohira M, Nagayama D, Tatsuno I, Shimizu K, Takahashi M, Takahara A.

Curr Hypertens Rev. 2013 Feb;9(1):66-75. doi: 10.2174/1573402111309010010. Review.

9.

Values of cardio-ankle vascular index (CAVI) between Amami islands and Kagoshima mainland among health checkup examinees.

Hirasada K, Niimura H, Kubozono T, Nakamura A, Tatebo M, Ogawa S, Tsunematsu N, Chiba S, Matsushita T, Kusano K, Miyata M, Takezaki T.

J Atheroscler Thromb. 2012;19(1):69-80. Epub 2011 Nov 21.

10.

The correlation between the cardio-ankle vascular index (CAVI) and serum amyloid A in asymptomatic Japanese subjects.

Kotani K, Yamada T, Miyamoto M, Kario K, Ishibashi S, Taniguchi N.

Heart Vessels. 2012 Sep;27(5):499-504. doi: 10.1007/s00380-011-0182-9. Epub 2011 Sep 3.

PMID:
21892740
11.

[Cardio-ankle vascular index (CAVI) and cardiovascular disease].

Takata M, Shimakura A.

Rinsho Byori. 2013 Oct;61(10):924-33. Review. Japanese.

PMID:
24371997
12.

Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.

Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N, Murano T, Miyashita Y, Shirai K.

Diabetes Res Clin Pract. 2007 Apr;76(1):93-101. Epub 2006 Sep 7.

PMID:
16956692
13.

Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.

Miyashita Y, Shirai K, Itoh Y, Sasaki H, Totsuka M, Murano T, Watanabe H.

Diabetes Res Clin Pract. 2002 Jun;56(3):181-7.

PMID:
11947965
14.

Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome.

Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Ooishi M, Kotani K, Ogawa Y.

Hypertens Res. 2008 Oct;31(10):1921-30. doi: 10.1291/hypres.31.1921.

PMID:
19015600
15.

The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.

Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T, Miyashita Y, Shirai K.

Diabetes Res Clin Pract. 2006 Dec;74(3):242-8. Epub 2006 May 19.

PMID:
16713009
16.

Association between arterial stiffness and pulmonary function in hypertensive patients.

Masugata H, Senda S, Okada H, Murao K, Inukai M, Himoto T, Hosomi N, Murakami K, Noma T, Kohno M, Goda F.

Hypertens Res. 2012 Apr;35(4):388-92. doi: 10.1038/hr.2011.199. Epub 2011 Nov 24.

PMID:
22113357
17.

Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.

Hitsumoto T, Takahashi M, Iizuka T, Shirai K.

J Cardiol. 2006 Aug;48(2):65-73.

PMID:
16948449
18.

A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

Shirai K, Utino J, Otsuka K, Takata M.

J Atheroscler Thromb. 2006 Apr;13(2):101-7.

19.

Oxidized lipoprotein(a) and cardio-ankle vascular index (CAVI) in hypertensive subjects.

Kotani K, Yamada S, Yamada T, Kario K, Taniguchi N.

Heart Vessels. 2013 Jul;28(4):461-6. doi: 10.1007/s00380-012-0265-2. Epub 2012 Jun 19.

PMID:
22710560
20.

Association between the Postprandial Glucose Levels and Arterial Stiffness Measured According to the Cardio-ankle Vascular Index in Non-diabetic Subjects.

Tsuboi A, Ito C, Fujikawa R, Yamamoto H, Kihara Y.

Intern Med. 2015;54(16):1961-9. doi: 10.2169/internalmedicine.54.3596. Epub 2015 Aug 15.

Supplemental Content

Support Center